Impaired activity of the gamma-glutamyl cycle in nephropathic cystinosis fibroblasts

Pediatr Res. 2006 Feb;59(2):332-5. doi: 10.1203/01.pdr.0000196370.57200.da.


Cystinotic patients have been shown to excrete in their urine high levels of pyroglutamate, an intermediate metabolite of the adenosine triphosphate (ATP)-dependent gamma-glutamyl cycle, which is responsible for glutathione (GSH) synthesis. Human fibroblasts were used to study the mechanisms leading to pyroglutamate accumulation in nephropathic cystinosis (NC). We show that inhibition of ATP synthesis caused a marked intracellular accumulation of pyroglutamate, reflecting decreased GSH synthesis. Despite similar degrees of ATP depletion, pyroglutamate increased more in cystinotic fibroblasts than in controls, while GSH decreased to lower levels. In addition, cystinotic cells exposed to oxidative stress (hydrogen peroxide) were unable to increase their GSH concentration above baseline. These results could not be attributed to differences in mitochondrial oxidative activity or to increased apoptotic cell death. Together, these results support the hypothesis that cysteine derived from lysosomal cystine efflux limits the activity of the gamma-glutamyl cycle and GSH synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Citrate (si)-Synthase / metabolism
  • Cystinosis / metabolism*
  • Cystinosis / pathology
  • Electron Transport
  • Electron Transport Complex IV / metabolism
  • Fibroblasts / metabolism
  • Glutamic Acid / metabolism*
  • Glutathione / metabolism
  • Humans
  • Oxidative Stress
  • Pyrrolidonecarboxylic Acid / metabolism


  • Glutamic Acid
  • Adenosine Triphosphate
  • Electron Transport Complex IV
  • Citrate (si)-Synthase
  • Glutathione
  • Pyrrolidonecarboxylic Acid